Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/nmda-antagonists-potentiate-antiparkinsonian-actions-of-l-dopa-in-C1s8KMUNR6
References (35)
-
G. Paxinos, Charles Watson (1983)
The Rat Brain in Stereotaxic Coordinates -
A. Crossman, D. Peggs, S. Boyce, M. Luquin, M. Sambrook (1989)
Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkeyNeuropharmacology, 28
-
H. Pan, J. Penney, A. Young (1985)
γ‐Aminobutyric Acid and Benzodiazepine Receptor Changes Induced by Unilateral 6‐Hydroxydopamine Lesions of the Medial Forebrain BundleJournal of Neurochemistry, 45
-
Tricklebank Tricklebank, Singh Singh, Oles Oles (1989)
The behavioural effects of MK‐801: a comparsion with antagonists acting noncompetitively at the NMDA receptorEur J Pharmacol, 167
-
P. Sonsalla, W. Nicklas, R. Heikkila (1989)
Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.Science, 243 4889
-
W. Schmidt, M. Bubser (1989)
Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in ratsPharmacology Biochemistry and Behavior, 32
-
Task-dependent impairment or facilitation of learning by NMDA receptor blockade -
R. Balgir (1986)
Serological markers in unipolar and bipolar affective disorders.Human heredity, 36 4
-
Snyder Snyder, D'Amato D'Amato (1986)
MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's diseaseNeurology, 36
-
(1990)
N-methyl-D-aspartate antagonisrs protect substantia nigra from MPP+ neurotoxicity -
M. Thiébot, J. Kloczko, R. Chermat, P. Soubrié, A. Puech, P. Simon (1982)
A simple model for studying benzodiazepines: Potentiation of hyperactivity induced by cocaine in miceDrug Development Research, 2
-
Carlsson Carlsson, Carlsson Carlsson (1989)
Dramatic synergism between MK‐801 and clonidine with respect to locomotor stimulatory effect in monoamine‐depleted miceJ Neural Transm, 77
-
M. Tricklebank, L. Singh, R. Oles, Cliff Preston, S. Iversen (1989)
The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.European journal of pharmacology, 167 1
-
G. Alexander, M. DeLong, P. Strick (1986)
Parallel organization of functionally segregated circuits linking basal ganglia and cortex.Annual review of neuroscience, 9
-
Y. Smith, A. Parent (1988)
Neurons of the subthalamic nucleus in primates display glutamate but not GABA immunoreactivityBrain Research, 453
-
(1984)
y-Aminobutyric acid and basal ganglia outflow pathways -
J. Kornhuber, J. Bormann, W. Retz, Marianne Hübers, P. Riederer (1989)
Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex.European journal of pharmacology, 166 3
-
W. Miller, M. DeLong (1987)
Altered Tonic Activity of Neurons in the Globus Pallidus and Subthalamic Nucleus in the Primate MPTP Model of Parkinsonism -
T. Klockgether, L. Turski (1989)
Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's diseaseTrends in Neurosciences, 12
-
Solomon Snyder, R. D'Amato (1986)
MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture.Neurology, 36 2
-
B. Rouzaire‐Dubois, E. Scarnati (1987)
Pharmacological study of the cortical-induced excitation of subthalamic nucleus neurons in the rat: Evidence for amino acids as putative neurotransmittersNeuroscience, 21
-
J. Scheel‐Krüger (1986)
Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.Acta neurologica Scandinavica. Supplementum, 107
-
J. Olney, M. Price, J. Labruyere, K.Shahid Salles, Gregory Frierdich, Mary Mueller, Emily Silverman (1987)
Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists.European journal of pharmacology, 142 2
-
S. Kitai, H. Kita (1987)
Anatomy and Physiology of the Subthalamic Nucleus: A Driving Force of the Basal Ganglia -
R. Albin, A. Young, J. Penney (1989)
The functional anatomy of basal ganglia disordersTrends in Neurosciences, 12
-
I. Mitchell, C. Clarke, S. Boyce, R. Robertson, D. Peggs, M. Sambrook, A. Crossman (1989)
Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeuroscience, 32
-
B. Clineschmidt, G. Martin, P. Bunting (1982)
Anticonvulsant activity of (+)‐5‐methyl‐10, 11‐dihydro‐5H‐dibenzo[a, d]cyclohepten‐5, 10‐imine (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Development Research, 2
-
G. Steg (1964)
EFFERENT MUSCLE INNERVATION AND RIGIDITY.Acta physiologica Scandinavica. Supplementum
-
Carlsson Carlsson, Carlsson Carlsson (1989)
The NMDA antagonist MK‐801 causes marked locomotor stimulation in monoamine‐depleted miceJ Neural Transm, 75
-
W. Koek, J. Woods, G. Winger (1988)
MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.The Journal of pharmacology and experimental therapeutics, 245 3
-
Klockgether Klockgether, Schwarz Schwarz, Turski Turski (1985)
Rigidity and catalepsy after injections of muscimol into the ventromedial thalamic nucleus: an electromyograhic study in the ratExp Brain Res, 58
-
L. Turski, M. Schwarz, W. Turski, T. Klockgether, K. Sontag, J. Collins (1985)
Muscle relaxant action of excitatory amino acid antagonistsNeuroscience Letters, 53
-
Clineschmidt Clineschmidt, Martin Martin, Bunting Bunting, Papp Papp (1982)
Central sympathomimetic activity of (+)5‐methyl‐10,11‐dihydro‐5H‐dibenzo(a, d)cyclohepten‐5,10‐imine maleate (MK‐801), a substance with potent anticonvulsant, central sympathomimetic, and apparent anxiolytic propertiesDrug Dev Res, 2
-
(1987)
A preliminary study of PCP-like behavioral effects of 2-amino-5-phosphonovalerate in rhesus monkey -
R. Morris, Elizabeth Anderson, G. Lynch, M. Baudry (1986)
Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5Nature, 319
- Publisher
- Wiley
- Copyright
- Copyright © 1990 American Neurological Association
- ISSN
- 0364-5134
- eISSN
- 1531-8249
- DOI
- 10.1002/ana.410280411
- pmid
- 2252365
- Publisher site
- See Article on Publisher Site
Abstract
Systemically administered N‐methyl‐D‐aspartate (NMDA) antagonists, MK‐801((+)5‐methyl‐10,11‐dihydro‐5H‐dibenzo(a, d)cyclohepten‐5,10‐imine maleate) and CPP(3‐((±)‐2‐carboxypiperazin‐4‐y1)‐propyl‐1‐phosphonate), potentiate the ability of L‐dopa (L‐3,4‐dihydroxyphenylalanine) to reverse akinesia and to alleviate muscular rigidity in monoamine‐depleted rats. On the basis of these findings, it is proposed that NMDA antagonists may be beneficial as adjunctive treatment in the therapy of Parkinson's disease. CPP locally injected into the subthalamic nucleus, entopeduncular nucleus–the rat homologue of the internal pallidal segment–or substantia nigra pars reticulata of monoamine‐depleted rats stimulates locomotor activity and alleviates rigidity, whereas local microinjection of CPP into the neostriatum is ineffective. These results make it unlikely that the neostriatum is the site of the antiparkinsonian action of NMDA antagonists in monoamine‐depleted rats, whereas the subthalamic nucleus, internal pallidal segment, and substantia nigra pars reticulata appear to be important for the effects of NMDA antagonists.
Journal
Annals of Neurology – Wiley
Published: Oct 1, 1990